Rare Hepatobiliary Disorders: Imaging Spectrum of Caroli Disease


Caroli Disease Imaging: MRI Findings, Central Dot Sign, and the Future of AI-Assisted Hepatobiliary Diagnosis

Introduction

Rare hepatobiliary disorders often present significant diagnostic challenges for radiologists, hepatologists, and gastroenterologists. Among these uncommon entities, Caroli disease occupies a unique position because its imaging appearance can be highly characteristic when recognized correctly, yet easily overlooked when encountered infrequently.

Caroli disease is a congenital fibropolycystic liver disorder characterized by segmental or diffuse non-obstructive dilatation of the intrahepatic bile ducts. Although considered rare, accurate recognition is critical because delayed diagnosis may lead to recurrent cholangitis, hepatolithiasis, hepatic fibrosis, portal hypertension, and ultimately liver failure.

Modern imaging techniques, particularly MRI and MRCP, have transformed the diagnostic approach. Even more exciting is the emergence of artificial intelligence (AI) tools capable of assisting radiologists in detecting subtle hepatobiliary abnormalities and improving workflow efficiency.

This article reviews the imaging spectrum of Caroli disease, highlights the diagnostic significance of the Central Dot Sign, discusses differential diagnoses, and explores how AI may reshape hepatobiliary imaging over the next decade.


Clinical Background

Caroli disease is an autosomal recessive congenital disorder resulting from malformation of the ductal plate during embryologic development.

The disease exists in two forms:

Caroli Disease

Characterized by isolated cystic dilatation of large intrahepatic bile ducts.

Caroli Syndrome

Associated with:

  • Congenital hepatic fibrosis

  • Portal hypertension

  • More diffuse biliary involvement

  • Increased clinical severity

Patients may remain asymptomatic for years before developing:

  • Recurrent abdominal pain

  • Fever

  • Jaundice

  • Recurrent bacterial cholangitis

  • Hepatomegaly

  • Biliary stone formation

The presented case involved a 25-year-old woman with abdominal pain and elevated liver function tests. Ultrasound and MRI demonstrated characteristic imaging findings leading to diagnosis.


Pathophysiology

The fundamental abnormality is incomplete remodeling of embryonic bile ducts.

This results in:


Persistent bile stasis is responsible for many complications encountered clinically.


Imaging Findings

Ultrasound Findings

Figure 1. Ultrasound

Ultrasound often represents the first-line imaging examination.

Typical findings include:

  • Multiple cystic structures

  • Communication with the biliary tree

  • Predominantly intrahepatic distribution

  • Associated biliary dilatation

In this case, ultrasound demonstrated multiple cystic structures communicating with the intrahepatic biliary system.

Important ultrasound clues include:

  • Branching cystic appearance

  • Portal vein branches traversing lesions

  • Absence of solid nodules

  • Associated hepatomegaly


MRI Findings

MRI is considered the gold standard imaging modality.

Figure 2. T2WI Coronal

Figure 3. T2WI Axial

Advantages include:

  • Excellent tissue contrast

  • Visualization of biliary communication

  • Detection of fibrosis

  • Assessment of complications

Key MRI findings include:

  • Segmental saccular dilatation

  • Fusiform biliary enlargement

  • Communication with the bile ducts

  • Hepatic lobe hypertrophy

The presented MRI demonstrated enlargement of the left and caudate lobes with marked intrahepatic biliary dilatation.


The Central Dot Sign

The most important imaging hallmark of Caroli disease is the Central Dot Sign.

This sign represents:

Portal Vein Branch

Fibrous Tissue

within

Dilated Intrahepatic Bile Duct

On MRI, the finding appears as a tiny enhancing focus surrounded by fluid-filled dilated ducts.

Recognition of the central dot sign dramatically increases diagnostic confidence.

The case demonstrated the classic central dot sign around portal venous structures.


Differential Diagnosis

Polycystic Liver Disease

Features:

  • Numerous cysts

  • No biliary communication

  • No central dot sign

Biliary Hamartomas

Features:

  • Small scattered cystic lesions

  • No communication with the biliary tree

Primary Sclerosing Cholangitis

Features:

  • Multifocal strictures

  • Beaded appearance

  • Chronic inflammatory changes

Obstructive Biliary Dilatation

Features:

  • Upstream dilation

  • Mechanical obstruction identified

Distinguishing communication with the biliary tree is the most important differentiating feature.


MRCP Findings

MRCP has become indispensable.

Figure 4. MRCP

Benefits include:

  • Non-invasive imaging

  • Visualization of ductal communication

  • Stone detection

  • Surgical planning

Typical MRCP appearance:

  • Saccular dilated ducts

  • Branching morphology

  • Communication with larger biliary channels


AI Applications in Hepatobiliary Imaging

Artificial intelligence is increasingly integrated into abdominal imaging.

Computer Vision

Algorithms can automatically:

  • Segment liver anatomy

  • Identify biliary structures

  • Detect ductal abnormalities

Deep Learning

Neural networks may:

  • Detect rare diseases

  • Improve lesion characterization

  • Reduce interpretation variability

Foundation Models

Emerging multimodal foundation models combine:

  • Imaging

  • Laboratory data

  • Clinical notes

  • Genomic information

to improve diagnostic precision.

Clinical Decision Support Systems

AI-driven platforms may assist radiologists by:

  • Highlighting suspicious biliary abnormalities

  • Suggesting differential diagnoses

  • Providing evidence-based recommendations


Diagnostic Workflow



Treatment and Management

There is currently no definitive cure.

Management focuses on:

Medical Therapy

  • Antibiotics

  • Symptom control

  • Management of cholangitis

Interventional Therapy

  • Biliary drainage

  • Stone removal procedures

Surgical Therapy

  • Segmental hepatic resection

Advanced Disease

  • Liver transplantation

The literature suggests transplantation may be required for diffuse disease and severe complications.


Enterprise Imaging and High-RPM Healthcare Technologies

Healthcare executives increasingly invest in:

  • Enterprise AI Platforms

  • PACS Modernization

  • Cloud Imaging Infrastructure

  • AI Diagnostic Software

  • Clinical Decision Support Systems

These technologies represent some of the highest-value sectors within healthcare IT and medical imaging.

Future hepatobiliary imaging will likely integrate:


creating fully connected diagnostic ecosystems.


Key Imaging Pearls

  1. Central dot sign is highly characteristic.

  2. MRI is superior to ultrasound for diagnosis.

  3. MRCP demonstrates biliary communication.

  4. Disease is congenital.

  5. Recurrent cholangitis is common.

  6. Hepatolithiasis frequently develops.

  7. Portal hypertension suggests Caroli syndrome.

  8. Differentiate from polycystic liver disease.

  9. Evaluate for renal abnormalities.

  10. Long-term surveillance is essential.


Future Perspectives

Within the next decade, we may see:

  • Automated biliary segmentation

  • AI-based rare disease detection

  • Foundation models in radiology

  • Predictive analytics for cholangitis risk

  • Digital twin liver simulations

  • Precision hepatology platforms

Radiologists will increasingly collaborate with AI rather than compete against it.


Conclusion

Caroli disease remains a rare but important congenital hepatobiliary disorder. Recognition of characteristic imaging findings, especially the central dot sign and communicating intrahepatic biliary dilatation, enables accurate diagnosis. MRI and MRCP are central to evaluation, while AI technologies are poised to revolutionize detection, characterization, and management. Early diagnosis can prevent complications and improve long-term outcomes, making imaging expertise essential in modern hepatobiliary medicine.


Key Takeaways

  • Caroli's disease is a rare congenital biliary disorder.

  • MRI and MRCP are the preferred diagnostic modalities.

  • Central Dot Sign is the hallmark imaging feature.

  • Differential diagnosis includes PSC, biliary hamartoma, and polycystic liver disease.

  • AI is increasingly valuable in hepatobiliary imaging workflows.

  • Early diagnosis can prevent recurrent cholangitis and liver failure.

References

  1. Brancatelli G, et al. Fibropolycystic liver disease: CT and MR imaging findings. Radiographics. 2005;25(3):659-670. DOI: 10.1148/rg.253045114.

  2. Levy AD, et al. Caroli's disease: Radiologic spectrum with pathologic correlation. AJR. 2002;179(4):1053-1057. DOI: 10.2214/AJR.179.4.1791053.

  3. Yonem O, Bayraktar Y. Clinical characteristics of Caroli syndrome. World J Gastroenterol. DOI: 10.3748/wjg.v13.i13.1934

  4. Desmet VJ. Congenital diseases of intrahepatic bile ducts. Hepatology. DOI: 10.1002/hep.1840160610

Comments

Popular posts from this blog

Understanding Tubal Ligation Clips: Imaging, Risks, Migration, and Management

Teres Minor Atrophy: Causes, Imaging, and Clinical Implications

The Lethal Lens: Mastering the Diagnosis and Management of Epidural Hemorrhage (EDH)